Skip to main content
Medicine LibreTexts

21.7: Review Questions

  1. Last updated
  2. Save as PDF
  • Page ID
    90679

    • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\dsum}{\displaystyle\sum\limits} \)

    \( \newcommand{\dint}{\displaystyle\int\limits} \)

    \( \newcommand{\dlim}{\displaystyle\lim\limits} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \(\newcommand{\longvect}{\overrightarrow}\)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \(\newcommand{\ket}[1]{\left| #1 \right>}\)
    \(\newcommand{\bra}[1]{\left< #1 \right|}\)
    \(\newcommand{\braket}[2]{\left< #1 \vphantom{#2} \right| \left. #2 \vphantom{#1} \right>}\)
    \(\newcommand{\braopket}[3]{\left< #1 \vphantom{#2}\vphantom{#3} \right| #2 \vphantom{#1}\vphantom{#3} \left| #3 \vphantom{#1}\vphantom{#2} \right>}\)
    \(\newcommand{\qmvec}[1]{\mathbf{\vec{#1}}}\)
    \(\newcommand{\op}[1]{\hat{\mathbf{#1}}}\)
    \(\newcommand{\expect}[1]{\langle #1 \rangle}\)
    \(\newcommand{\dfn}[1]{\emph{\textbf{#1}}}\)

    \(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)
    Exercise \(\PageIndex{1}\)

    A nurse is explaining a client’s lipid panel results. Which statement by the client indicates a need for further teaching?

  • “LDL-cholesterol is ‘bad cholesterol.’”
  • “Medications can be used to increase my triglyceride levels.”
  • “HDL-cholesterol is ‘good cholesterol.’”
  • “Medications can decrease my cholesterol levels.”
    • Answer

    “Medications can be used to increase my triglyceride levels.”

    Exercise \(\PageIndex{2}\)

    A nurse is explaining administration instructions for a client who is starting alirocumab, a PCSK9 inhibitor. Which statement will the nurse include in the instructions?

  • It can be taken orally at bedtime.
  • It is self-administered as a subcutaneous injection by the client.
  • It is administered as a subcutaneous injection by a health care professional.
  • It comes in a powder form that must be mixed with liquid before taking.
    • Answer

    It is self-administered as a subcutaneous injection by the client.

    Exercise \(\PageIndex{3}\)

    A client began treatment for severe hypertriglyceridemia and goes to the clinic for follow-up. Which medication does the nurse expect to find on the client’s home medication list?

  • Ezetimibe
  • Cholestyramine
  • Colesevelam
  • Fenofibrate
    • Answer

    Fenofibrate

    Exercise \(\PageIndex{4}\)

    A client calls the nurse because they experienced intolerable flushing after taking over-the-counter niacin. Which intervention might the nurse recommend?

  • Take flush-free niacin.
  • Switch to immediate-release niacin.
  • Take aspirin 30 minutes before taking niacin.
  • Take niacin with an alcoholic beverage.
    • Answer

    Take aspirin 30 minutes before taking niacin.

    Exercise \(\PageIndex{5}\)

    A nurse is evaluating a follow-up lipid panel in a client who recently began taking ezetimibe. Which of the following changes would the nurse expect to see?

  • Decreased HDL-cholesterol level
  • Decreased LDL-cholesterol level
  • Increased triglyceride level
  • Increased VLDL level
    • Answer

    Decreased LDL-cholesterol level

    Exercise \(\PageIndex{6}\)

    A nurse educator is training new nurses on the cardiac step-down unit about medications administered on the unit. Which statement indicates understanding of the drug cholestyramine?

  • It can cause diarrhea as the major adverse effect.
  • It should be taken in the morning when cholesterol synthesis is highest.
  • It is available as an oral powder that must be mixed with fluid before taking.
  • It works primarily to lower triglyceride levels in clients with hypertriglyceridemia.
    • Answer

    It is available as an oral powder that must be mixed with fluid before taking.

    Exercise \(\PageIndex{7}\)

    A client is admitted to the cardiac unit after undergoing stent placement after an acute myocardial infarction. The provider states that the client will need high-intensity statin therapy. Which medication does the nurse expect to be ordered for the client?

  • Simvastatin
  • Pravastatin
  • Rosuvastatin
  • Fluvastatin
    • Answer

    Rosuvastatin

    Exercise \(\PageIndex{8}\)

    Which of the following statements is true about pravastatin?

  • It is considered a hydrophilic statin, which means it may confer a lower risk of myalgia compared with other statins.
  • The FDA has issued a statement that doses of 80 mg are no longer appropriate due to myalgia risk.
  • It is metabolized by CYP3A4 and is subject to many drug interactions.
  • It is considered a high-intensity statin.
    • Answer

    It is considered a hydrophilic statin, which means it may confer a lower risk of myalgia compared with other statins.

    Exercise \(\PageIndex{9}\)

    A client with a past medical history of CAD has been taking rosuvastatin 40 mg orally daily for 1 month and has a follow-up LDL-cholesterol level of 135 mg/dL, which exceeds their goal LDL-cholesterol level of 70 mg/dL. Which would be an appropriate next step for the client?

  • Add gemfibrozil for combination therapy.
  • Change administration to bedtime rather than morning.
  • Change to pravastatin 80 mg orally daily.
  • Add ezetimibe for combination therapy.
    • Answer

    Add ezetimibe for combination therapy.

    Exercise \(\PageIndex{10}\)

    A client is taking atorvastatin. Which severe adverse drug reaction should the client be monitored for?

  • Rhabdomyolysis
  • Stroke
  • Severe constipation
  • Myocardial infarction
    • Answer

    Rhabdomyolysis

    This page titled 21.7: Review Questions was last modified on Sun, 29 Dec 2024 09:21:31 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax.